MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Personal Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
MENUMENU
  • About Us
    • Statement From CEO
    • Our Leadership
    • Partnerships
  • Programs
    • Personal Cancer Immunotherapy
    • The Clean Super Vaccine
    • Publications
  • News & Media
  • Contact Us
    • Contact Us
    • Careers
  •  

Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical’s Phase 2 Clinical Trial

IRVINE, Calif. – August 14, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical Receives Import Approval to Distribute its Professional ROOT of SKIN™ MD Skincare Line in Japan

IRVINE, Calif. – August 1, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical to Exhibit Skincare Products at ‘The Aesthetic Show’ and ‘AAD Summer Meeting’ in July

IRVINE, Calif. – July 11, 2019 – AIVITA Biomedical Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical Announces New Clinical Data in Ongoing Phase 2 Brain Cancer Trial

IRVINE, Calif. – July 8, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

ROOT OF SKIN™ Skincare Line Sells out in Eighth Consecutive Appearance on QVC Japan

IRVINE, Calif. – July 3, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical Presents New Clinical Data at 2019 ASCO Annual Meeting

IRVINE, Calif. – June 3, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical to Present at 2019 BIO International Convention Detailing New Clinical Data from Phase 2 Glioblastoma Trial

IRVINE, Calif. – May 31, 2019 – AIVITA Biomedical, a biotech company specializing in innovative stem cell applications, today…

AIVITA Biomedical to Present at Oncology, Biotech and Aesthetics Conferences in June

IRVINE, Calif. – May 31, 2019 – AIVITA Biomedical Inc., a biotech company specializing in innovative stem cell applications,…

AIVITA Biomedical to Present at Aesthetics and Regenerative Medicine Conferences in May

IRVINE, Calif. – May 8, 2019 – AIVITA Biomedical today announced that it will be exhibiting at two upcoming…

AIVITA Biomedical Expands Japan Distribution of its ROOT of SKIN™ Skincare Line

IRVINE, Calif. – April 22, 2019 – AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications,…

  • Previous
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next

AIVITA Biomedical is a biotechnology company developing personalized vaccines that target infectious diseases and tumor-initiating cells — the seed of all cancers — using our autologous cell platform. We leverage our unique expertise in stem cell growth and directed, high-purity differentiation to develop safe, efficient and economical manufacturing processes for therapeutic development in cancer, infectious disease and other fields.

Recent News

  • AIVITA Biomedical Licenses Novel Skincare Formulations to Global Skincare Retailer LevEllis
  • AIVITA Biomedical CEO Dr. Hans Keirstead and CMO Dr. Robert Dillman to Speak and Participate in Keynote Panel at Festival of Biologics USA
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Join Keynote Panel for AI in Public Health at World Vaccine Congress
  • AIVITA Biomedical Strengthens Board of Directors with Appointment of Ex-Biogen CEO Michel Vounatsos
  • AIVITA Biomedical CEO Dr. Hans Keirstead to Present at Biotech Showcase 2024

Site Navigation

  • About Us
  • Programs
  • News & Media
  • Contact Us
Copyright © 2023 | AIVITA Biomedical, Inc.